Emmaus Life Sciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.1M | $1.4M | $2.5M | $2.0M | $2.3M | $2.5M | $1.8M | $3.9M |
| Accounts Receivable | $2.8M | $2.6M | $5.5M | $375.0K | $1.0M | $198.0K | $2.2M | $1.8M |
| Inventory | $1.6M | $1.6M | $1.7M | $2.4M | $4.4M | $7.1M | $8.0M | $4.7M |
| Total Current Assets | $7.7M | $6.8M | $11.5M | $6.3M | $9.1M | $11.3M | $41.2M | $60.6M |
| Property, Plant & Equipment | $113.0K | $46.0K | $59.0K | $75.0K | $147.0K | $120.0K | $151.0K | $152.0K |
| Goodwill | — | — | — | — | — | — | — | $1.4M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | $116.5K |
| Total Assets | $21.4M | $23.6M | $35.2M | $48.2M | $56.7M | $59.5M | $59.5M | $75.3M |
| Liabilities | ||||||||
| Accounts Payable | $6.0M | $5.2M | $5.1M | $3.8M | $2.7M | $2.0M | $7.3M | $3.5M |
| Total Current Liabilities | $69.1M | $63.6M | $61.5M | $54.3M | $37.1M | $23.4M | $32.8M | $45.6M |
| Long-Term Debt | $27.1M | $29.0M | $30.6M | $30.4M | $22.3M | $15.3M | — | $13.6M |
| Total Liabilities | $85.0M | $80.1M | $82.9M | $82.3M | $78.2M | $64.7M | $70.5M | $97.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-270.1M | $-262.6M | $-256.1M | $-252.3M | $-241.3M | $-225.1M | $-226.2M | $-171.4M |
| Total Stockholders' Equity | $-63.6M | $-56.5M | $-47.8M | $-34.1M | $-21.5M | $-5.2M | $-11.1M | $-21.7M |